'Druggability' of the Per-Arnt-Sim (PAS) domains of human PAS domain kinase, a therapeutic target for metabolic and liver disorders

人PAS结构域激酶的Per-Arnt-Sim (PAS)结构域的“成药性”:代谢和肝脏疾病的治疗靶点

阅读:2

Abstract

Per-Arnt-Sim (PAS) domain kinase (PASK) is a conserved metabolic sensor that modulates the activation of critical proteins involved in liver metabolism and fitness. However, despite its key role in mastering the metabolic regulation, the molecular mechanism of PASK's activity is ongoing research, and structural information of this important protein is scarce. To investigate this, we integrated structural bioinformatics with state-of-the-art modeling and molecular simulation techniques. Our goals were to address (1) how many regulatory PAS domains PASK is likely to have, (2) how those domains modulate the kinase activity, and (3) how those interactions could be controlled by small molecules. Our results indicated the existence of three N-terminal PAS domains. Solvent mapping and fragment docking identified a consensus set of 'druggable hot spots' within all domains, as well as at domain-domain interfaces. Those 'hot spots' could be modulated with chemically diverse small molecular probes, which may serve as a starting point for rationally designed therapeutics modulating these specific sites. Our results identified a plausible mechanism of autoinhibition of kinase activity, suggesting that all three putative PAS domains may be required. Future work will focus on validation of the predicted PASK models and development of small-molecule inhibitors of PASK by targeting its 'druggable hot spots'.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。